COMMENTARY ON THE DUNLEAVY/WILSON ARTICLE: Diffuse Large B-Cell Lymphoma: One Treatment No Longer Fits All

被引：0
作者：
Sehn, Laurie H. [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
ONCOLOGY-NEW YORK | 2014年 / 28卷 / 04期
关键词：
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; MOLECULAR SUBTYPES; CHOP; CHEMOTHERAPY; EXPRESSION; VINCRISTINE; DOXORUBICIN; SIGNATURES; SURVIVAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：334 / 336
页数：3
相关论文
共 20 条
  • [1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    Alizadeh, AA
    Eisen, MB
    Davis, RE
    Ma, C
    Lossos, IS
    Rosenwald, A
    Boldrick, JG
    Sabet, H
    Tran, T
    Yu, X
    Powell, JI
    Yang, LM
    Marti, GE
    Moore, T
    Hudson, J
    Lu, LS
    Lewis, DB
    Tibshirani, R
    Sherlock, G
    Chan, WC
    Greiner, TC
    Weisenburger, DD
    Armitage, JO
    Warnke, R
    Levy, R
    Wilson, W
    Grever, MR
    Byrd, JC
    Botstein, D
    Brown, PO
    Staudt, LM
    [J]. NATURE, 2000, 403 (6769) : 503 - 511
  • [2] Benito JM, 2012, BLOOD, V120
  • [3] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier, B
    Lepage, E
    Brière, J
    Herbrecht, R
    Tilly, H
    Bouabdallah, R
    Morel, P
    Van den Neste, E
    Salles, G
    Gaulard, P
    Reyes, F
    Gisselbrecht, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) : 235 - 242
  • [4] Dunleavy K, 2014, ONCOLOGY-NY, V28, P326
  • [5] Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
    Dunleavy, Kieron
    Pittaluga, Stefania
    Czuczman, Myron S.
    Dave, Sandeep S.
    Wright, George
    Grant, Nicole
    Shovlin, Margaret
    Jaffe, Elaine S.
    Janik, John E.
    Staudt, Louis M.
    Wilson, Wyndham H.
    [J]. BLOOD, 2009, 113 (24) : 6069 - 6076
  • [6] Gandhi M, 2013, ASH ANN M, V122
  • [7] Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
    Green, Tina Marie
    Young, Ken H.
    Visco, Carlo
    Xu-Monette, Zijun Y.
    Orazi, Attilio
    Go, Ronald S.
    Nielsen, Ole
    Gadeberg, Ole V.
    Mourits-Andersen, Torben
    Frederiksen, Mikael
    Pedersen, Lars Moller
    Moller, Michael Boe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : 3460 - 3467
  • [8] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, Thomas M.
    Weller, Edie A.
    Morrison, Vicki A.
    Gascoyne, Randy D.
    Cassileth, Peter A.
    Cohn, Jeffrey B.
    Dakhil, Shaker R.
    Woda, Bruce
    Fisher, Richard I.
    Peterson, Bruce A.
    Horning, Sandra J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127
  • [9] Higher Response to Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Nongerminal Center B-Cell-Like Than in Germinal Center B-Cell-Like Phenotype
    Hernandez-Ilizaliturri, Francisco J.
    Deeb, George
    Zinzani, Pier L.
    Pileri, Stefano A.
    Malik, Farhana
    Macon, William R.
    Goy, Andre
    Witzig, Thomas E.
    Czuczman, Myron S.
    [J]. CANCER, 2011, 117 (22) : 5058 - 5066
  • [10] MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
    Hu, Shimin
    Xu-Monette, Zijun Y.
    Tzankov, Alexander
    Green, Tina
    Wu, Lin
    Balasubramanyam, Aarthi
    Liu, Wei-min
    Visco, Carlo
    Li, Yong
    Miranda, Roberto N.
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    Zhao, Xiaoying
    van Krieken, J. Han
    Huang, Qin
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Zhou, Fan
    Slack, Graham W.
    Gascoyne, Randy D.
    Tu, Meifeng
    Variakojis, Daina
    Chen, Weina
    Go, Ronald S.
    Piris, Miguel A.
    Moller, Michael B.
    Medeiros, L. Jeffrey
    Young, Ken H.
    [J]. BLOOD, 2013, 121 (20) : 4021 - 4031
12